Evolution of the Average Target: Philips NV

Evolution of the Average Target - Philips NV

Evolution of the Target Price: Philips NV

Evolution of the Target Price - Philips NV

Changes in Analyst Recommendations: Philips NV

0e81.w3VnQ7e_N6YMW2HX9TdnkOm_SGOADtOIwBjd9aJwUJI.9A8LNeaJeeE5PwOjnA4v6oXgPibVT7rqknTqwsMHPcX1OAMH7egEw10LFg~ad29f10c5a9b6f01b387bbba268a88ad
12/10 Philips NV : RBC sticks Neutral ZD
09/10 Philips NV : JP Morgan reiterates its Neutral rating ZD
06/10 Philips NV : Gets a Neutral rating from Bernstein ZD
05/10 Philips NV : RBC reiterates its Neutral rating ZD
01/10 Philips NV : Deutsche Bank reiterates its Neutral rating ZD
30/09 Philips NV : Gets a Neutral rating from Bernstein ZD
29/09 Philips NV : Gets a Neutral rating from Jefferies ZD
09/09 Philips NV : JP Morgan reiterates its Neutral rating ZD
03/08 UBS Downgrades Koninklijke Philips to Neutral, Cuts PT MT
03/08 PHILIPS NV : UBS revises his opinion and turns to Neutral ZD
31/07 RBC Tweaks Philips Forecast After Q2 Results; Sector Perform Maintained MT
30/07 PHILIPS NV : Deutsche Bank reaffirms its Neutral rating ZD
29/07 PHILIPS NV : Receives a Buy rating from DZ Bank ZD
29/07 PHILIPS NV : Bernstein sticks Neutral ZD
29/07 PHILIPS NV : JP Morgan reiterates its Neutral rating ZD
28/07 Koninklijke Philips NV: Caution in Q3 overshadows the underlying business strength, presenting a buying opportunity Alphavalue
28/07 PHILIPS NV : RBC reiterates its Neutral rating ZD
28/07 PHILIPS NV : Bernstein remains Neutral ZD
28/07 PHILIPS NV : JP Morgan reaffirms its Neutral rating ZD
16/07 MedTech facing a three-front squeeze Alphavalue
07/07 PHILIPS NV : JP Morgan gives a Neutral rating ZD
07/07 PHILIPS NV : Jefferies is Neutral ZD
02/07 Bernstein: Philips Still On Track for FY26 Goals Despite Expected Q2 Margin Dip MT
30/06 PHILIPS NV : Bernstein remains Neutral ZD
30/06 RBC Tweaks Estimates for Philips on Currency Moves, Share Issuance; Sector Perform Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+12.89%
+8.35%
+12.03%
+8.24%
+28.32%
+11.63%
+8.42%
-4.12%
+2.57%
-0.57%
Average +8.78%
Weighted average by Cap. +9.28%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
23.78EUR
Average target price
26.84EUR
Spread / Average Target
+12.89%
High Price Target
35.00EUR
Spread / Highest target
+47.18%
Low Price Target
21.00EUR
Spread / Lowest Target
-11.69%

Analyst Consensus Detail

Analyst consensus - Philips NV

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Philips NV
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Philips NV
  1. Stock Market
  2. Stocks
  3. PHIA Stock
  4. Consensus Philips NV